Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Munn

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
Journal of Reproductive Immunology|April 6, 2004
Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specificBabak Baban, Phillip Chandler, Doris McCool, et al.
The Journal of Experimental Medicine|June 12, 2013
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4Rikke B Holmgaard, Dmitriy Zamarin, David H Munn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouseVijay Saxena, Jennifer K Ondr, Albert F Magnusen, et al.
Blood|February 2, 2010
Chemotherapy rescues tumor-driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotypeZhi-Chun Ding, Bruce R Blazar, Andrew L Mellor, et al.
Blood|September 2, 2011
Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?Celalettin Ustun, Jeffrey S Miller, David H Munn, et al.
European Journal of Immunology|March 9, 2007
Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cellsAnna K Manlapat, David J Kahler, Phillip R Chandler, et al.
Immunology|December 4, 2002
Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell divisionGeon Kook Lee, Hyeon Jin Park, Megan Macleod, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Lentivector immunization stimulates potent CD8 T cell responses against melanoma self-antigen tyrosinase-related protein 1 and generates antitumor immunity in miceYanjun Liu, Yibing Peng, Michael Mi, et al.
Vaccine|March 23, 2011
Lentivector expressing HBsAg and immunoglobulin Fc fusion antigen induces potent immune responses and results in seroconversion in HBsAg transgenic miceYuan Hong, Yibing Peng, Michael Mi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signalingAndrew L Mellor, Babak Baban, Phillip R Chandler, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
Journal of Reproductive Immunology|April 6, 2004
Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specificBabak Baban, Phillip Chandler, Doris McCool, et al.
The Journal of Experimental Medicine|June 12, 2013
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4Rikke B Holmgaard, Dmitriy Zamarin, David H Munn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouseVijay Saxena, Jennifer K Ondr, Albert F Magnusen, et al.
Blood|February 2, 2010
Chemotherapy rescues tumor-driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotypeZhi-Chun Ding, Bruce R Blazar, Andrew L Mellor, et al.
Blood|September 2, 2011
Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?Celalettin Ustun, Jeffrey S Miller, David H Munn, et al.
European Journal of Immunology|March 9, 2007
Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cellsAnna K Manlapat, David J Kahler, Phillip R Chandler, et al.
Immunology|December 4, 2002
Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell divisionGeon Kook Lee, Hyeon Jin Park, Megan Macleod, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Lentivector immunization stimulates potent CD8 T cell responses against melanoma self-antigen tyrosinase-related protein 1 and generates antitumor immunity in miceYanjun Liu, Yibing Peng, Michael Mi, et al.
Vaccine|March 23, 2011
Lentivector expressing HBsAg and immunoglobulin Fc fusion antigen induces potent immune responses and results in seroconversion in HBsAg transgenic miceYuan Hong, Yibing Peng, Michael Mi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signalingAndrew L Mellor, Babak Baban, Phillip R Chandler, et al.
Pageof 15